Cancer Chemo- and Immunopharmacology: 1. Chemopharmacology by F. M. Muggia, J. Henney, V. DeVita Jr. (auth.), Professor

By F. M. Muggia, J. Henney, V. DeVita Jr. (auth.), Professor Georges Mathé, Professor Franco M. Muggia (eds.)

Show description

Read or Download Cancer Chemo- and Immunopharmacology: 1. Chemopharmacology PDF

Similar cancer books

Johns Hopkins Patients' Guide To Lung Cancer

Johns Hopkins sufferers' consultant to Lung melanoma is a concise, easy-to-follow “how to” advisor that places you at the route to health through explaining lung melanoma therapy from begin to end. It courses you thru the overpowering maze of remedy judgements, simplifies the advanced agenda that lies forward, and plays the duty of placing jointly your plan of care in layman's phrases.

Anthracycline Antibiotics in Cancer Therapy: Proceedings of the International Symposium on Anthracycline Antibiotics in Cancer Therapy, New York, New York, 16–18 September 1981

F. M. MUGGIA whilst confronted with the inadequacies of present melanoma remedy, we wish to examine what the long run could carry. normally, we take without any consideration the earlier, who prefer study into completely new parts. notwithstanding, the chronic improvement of fertile soil may well yield outstanding rewards in the event you decide to construct at the wisdom of the past--hence, this symposium on anthracycline antibiotics.

Oral Complications of Cancer Chemotherapy

This new paintings on oral issues of melanoma chemotherapy is edited by means of dentists who've made pioneering contributions during this formerly ignored sector. Their efforts have tested the helpful position of the dentist in oncologic examine and melanoma sufferer administration. The editors have accumulated 9 chapters that might be of curiosity to dentists and dental hygienists, oncology nurses, and all physicians treating melanoma sufferers with chemo­ healing brokers.

Psychological Aspects of Early Breast Cancer

Actual sickness can't be successfully taken care of except within the context of the mental elements with which it's linked. The physique can have the ailment, however it is the sufferer who's in poor health. learn psychologists from a few various backgrounds have, long ago few many years, became more and more to the examine of actual disorder, and there's now an in depth literature on preventive behaviors, the position of pressure within the etiology of disease, the patient's reactions to disease and its therapy, and the physician-patient courting.

Extra info for Cancer Chemo- and Immunopharmacology: 1. Chemopharmacology

Example text

The consequence of this kind of treatment is a selective antitumor effect. To avoid cytotoxic side effects, this therapeutic regimen must be monitored carefully. The decrease of the ratio of 3H-deoxyuridine (dUR)J3H-thymidine (dTR) incorporation into the DNA of the cells is a good biochemical parameter for estimating the MTX effect on rapidly proliferating cell systems. Using this indicator, it was shown that the usually administered dose of Leucovorin is not sufficient for an effective rescue of the bone marrow cells as long as the MTX serum concentration is equal or higher than 1O-6M.

A controlled study of chemo- and immunotherapy. Proc Am Soc Clin Oncol 20: 423 34 Salmon SE, Jones SE (eds) (1980) Adjuvant therapy of cancer II. Grune and Stratton, New York, pp 1-663 35 Maurer HM (1978) Intergroup Rhabdomyosarcoma Study (IRS): Current status. Proc Xth Meet Int Soc Pediatr Oncol, Bruxelles, p 23 36 Maurer HM, Moon T, Donaldson M, Fernandez C, Gehan EA, Hammond D, Hays DM, Lawrence W Jr, Newton W, Ragab A, Raney B, Soule EH, SutowWW, Tefft M (1977) The Intergroup Rhabdomyosarcoma Study.

This needs to be confirmed in phase III studies. One approach could be to treat larger numbers of patients with this regimen in an uncontrolled fashion. If the response rate stays in excess of 70%, relate it to the S. K. Carter 34 historical data base and decide the combination is superior. If the response rate should fall to 50% -60%, this would pose a problem since that would not be significantly higher than the 50% response rate that has been reported with methotrexate alone. An idealized, prospectively randomized, controlled trial would be as follows: ,-----DDP + bleomycin--P Methotrexate R I----DDP Randomize-----i 1 - - - - Bleomycin o G Methotrexate R E Methotrexate S '------Methotrexate S DDP I V E DISEASE + bleomycin As yet, neither of these types of trials have been undertaken and the true role of DDP in head and neck cancer still remains to be elucidated.

Download PDF sample

Rated 4.00 of 5 – based on 4 votes